Design and Synthesis of EZH2-Based PROTACs to Degrade the PRC2 Complex for Targeting the Noncatalytic Activity of EZH2Zhihao Liu, Luoting Yu, Xi Hu et al.|Journal of Medicinal Chemistry|2021Cited by 116
Nifuroxazide exerts potent anti-tumor and anti-metastasis activity in melanomaYongxia Zhu, Yuquan Wei, Tinghong Ye et al.|Scientific Reports|2016Cited by 72
Synthesis and structure–activity relationships evaluation of benzothiazinone derivatives as potential anti-tubercular agentsChao Gao, Luoting Yu, Tinghong Ye et al.|Bioorganic & Medicinal Chemistry Letters|2013Cited by 66
YLT-11, a novel PLK4 inhibitor, inhibits human breast cancer growth via inducing maladjusted centriole duplication and mitotic defectQian Lei, Luoting Yu, Lu Xiong et al.|Cell Death and Disease|2018Cited by 65
Discovery and structure–activity relationships study of novel thieno[2,3-b]pyridine analogues as hepatitis C virus inhibitorsNingyu Wang, Luoting Yu, Weiqiong Zuo et al.|Bioorganic & Medicinal Chemistry Letters|2014Cited by 50